Skip to main content
. 2026 Jul 18;27(14):6396. doi: 10.3390/ijms27146396
5-ALA 5-aminolevulinic acid
5-FU 5-fluorouracil
AFL/AFXL Ablative Fractional Lasers
AK/AKs Actinic Keratosis/Actinic Keratoses
AuNPs Gold nanoparticles
BCC/BCCs Basal Cell Carcinoma/Basal Cell Carcinomas
BCNS Basal Cell Nevus Syndrome
BD Bowen’s disease
CBCL Cutaneous B-cell Lymphomas
cPDT Conventional Photodynamic Therapy
CR Complete Response
cSCC Cutaneous Squamous Cell Carcinoma
DAMPs Damage-Associated Molecular Patterns
dPDT Daylight Photodynamic Therapy
ePDT Epigenetically Enhanced Photodynamic Therapy
MAL Methyl Aminolevulinate
MOFs Metal–Organic Frameworks
mPTP Mitochondrial Permeability Transition Pore
nBCC Nodular Basal Cell Carcinoma
NIR Near-Infrared
NK Natural Killer cells
NMSC/NMSCs Non-Melanoma Skin Cancer/Non-Melanoma Skin Cancers
OTRs Organ Transplant Recipients
PAKT Photodynamic therapy in Actinic Keratosis Treatment panel
pBCC Pigmented Basal Cell Carcinoma
PBGD Porphobilinogen Deaminase
PDT Photodynamic Therapy
PpIX Protoporphyrin IX
PTT Photothermal Therapy
ROS Reactive Oxygen Species
sBCC Superficial Basal Cell Carcinoma
SCC Squamous Cell Carcinoma
SLNs Solid Lipid Nanoparticles
SOTRs Solid Organ Transplant Recipients
TLRs Toll-like Receptors
UV Ultraviolet